CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > Reproduction, Fertility and Development   
Reproduction, Fertility and Development
  Vertebrate reproductive science and technology
blank image Search
blank image blank image
blank image
  Advanced Search

Journal Home
About the Journal
Editorial Structure
Online Early
Current Issue
Just Accepted
All Issues
Special Issues
Research Fronts
Virtual Issues
Sample Issue
For Authors
General Information
Submit Article
Author Instructions
Open Access
Awards and Prizes
For Referees
Referee Guidelines
Review an Article
Annual Referee Index
For Subscribers
Subscription Prices
Customer Service
Print Publication Dates
Library Recommendation

blue arrow e-Alerts
blank image
Subscribe to our email Early Alert or RSS feeds for the latest journal papers.

red arrow Connect with us
blank image
facebook twitter logo LinkedIn

red arrow Connect with SRB
blank image
facebook TwitterIcon

Affiliated Societies

RFD is the official journal of the International Embryo Transfer Society and the Society for Reproductive Biology.

Article << Previous     |     Next >>   Contents Vol 22(1)


N. Klymiuk A, B. Kessler A, M. Kurome A, A. Wuensch A, C. Faber B, H. Nagashima C and E. Wolf B

A Chair for Molecular Animal Breeding and Biotechnology, Gene Center, LMU Munich, Munich, Germany;
B Institute of Pathology, LMU Munich, Munich, Germany;
C Laboratory of Developmental Engineering, Meiji University, Kawasaki, Japan

Export Citation


The development of a1,3-galactosyltransferase deficient pigs along with overexpression of complement regulatory proteins was an important step to overcome hyperacute rejection of pig organs transplanted into primates. However, the lack of galactose-α1,3-galactose (αGal) epitopes does not protect against subsequent rejection mechanisms, such as acute vascular rejection, which plays a crucial role to achieve prolonged graft survival in pig-to-human xenotransplantation. Acute vascular rejection involves incompatibilities between human blood and porcine endothelial cells, leading to coagulation disorders. Indeed, thrombotic microangiopathy is one of the key characteristics of rejected pig-to-primate grafts from aGal-deficient donor animals. One of the strategies to overcome this coagulation problem by genetic modification of donor pigs is expression of human thrombomodulin (TM) on the porcine endothelium. Although porcine TM is able to bind circulating human thrombin, the resulting heterodimer is unable to cleave human protein C, which promotes the coagulation cascade. We addressed this problem by the development of a vector placing the single-exon open reading frame of human TM under the control of a 6-kb promoter fragment obtained from the porcine TM gene. In addition, we replaced the 3′-untranslated region (UTR) by a polyadenylation box from the bovine growth hormone gene to avoid interferon-y-dependent destabilization of thrombomodulin transcripts. This vector was linked to a floxed neomycin cassette and transfected into porcine fetal fibroblasts. Positive cell clones were selected with G418, mixed, and then used for nuclear transfer. Donor fibroblasts were electrofused with enucleated oocytes resulting in 358 reconstructed embryos (91.1% fusion rate). One or two days later, 294 embryos were transferred to 3 synchronized gilts. In total, 8 cloned transgenic piglets with 1 or 2 independent integration sites of the transgene were born. Heart, kidney, lung, and liver of 5 founder animals were analyzed by immunohistochemistry They were found to express thrombomodulin strongly and strictly limited to the vascular endothelium of at least heart and kidney. The staining intensity was estimated qualitatively, by grading from weak to strong immunoreactivity (brown color, using DAB as chromogen). Cells from founder pigs expressing TM strongly have been used for recloning. The effect of human TM to normalize blood coagulation will be tested in experiments involving ex vivo perfusion of transgenic hearts and kidneys with human blood.

Supported by the Deutsche Forschungsgemeinschaft (FOR 535).

Reproduction, Fertility and Development 22(5305) 370–370   http://dx.doi.org/10.1071/RDv22n1Ab426
Published online: 08 December 2009

Top  Email this page

Legal & Privacy | Contact Us | Help


© CSIRO 1996-2016